ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 209,59
0,67%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Actualités

AMGN

Amgen (AMGN)

Amgen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMGN
DateHeureSourceTitreSymboleSociété
10/05/202422h02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMGNAmgen Inc
10/05/202401h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
09/05/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
03/05/202415h12IH Market NewsAmgen, Bock Up; Cloudflare, Expedia WeakNASDAQ:AMGNAmgen Inc
02/05/202422h01PR Newswire (US)AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
01/05/202413h00PR Newswire (US)AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024NASDAQ:AMGNAmgen Inc
29/04/202422h00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
26/04/202415h00PR Newswire (US)AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCYNASDAQ:AMGNAmgen Inc
16/04/202423h26PR Newswire (US)AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024NASDAQ:AMGNAmgen Inc
09/03/202418h20PR Newswire (US)AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024NASDAQ:AMGNAmgen Inc
06/03/202422h00PR Newswire (US)AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
29/02/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCENASDAQ:AMGNAmgen Inc
26/02/202415h00PR Newswire (US)AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIONASDAQ:AMGNAmgen Inc
19/02/202422h00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL ON RARE DISEASENASDAQ:AMGNAmgen Inc
14/02/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMGNAmgen Inc
09/02/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCENASDAQ:AMGNAmgen Inc
07/02/202411h49IH Market NewsMoody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market UpdatesNASDAQ:AMGNAmgen Inc
06/02/202423h05IH Market NewsU.S. Stocks Finish Choppy Trading Day Modestly HigherNASDAQ:AMGNAmgen Inc
06/02/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
06/02/202422h01PR Newswire (US)AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/02/202412h27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNASDAQ:AMGNAmgen Inc
02/02/202422h25IH Market NewsU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon ResultsNASDAQ:AMGNAmgen Inc
01/02/202422h00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
29/01/202411h00PR Newswire (Canada)deCODE genetics: A sequence variant that increases risk of pregnancy lossNASDAQ:AMGNAmgen Inc
17/01/202412h33IH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNASDAQ:AMGNAmgen Inc
10/01/202416h12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:AMGNAmgen Inc
10/01/202414h53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:AMGNAmgen Inc
10/01/202414h45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNASDAQ:AMGNAmgen Inc
03/01/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
02/01/202417h42Dow Jones NewsAmgen On Pace for Record High Close -- Data TalkNASDAQ:AMGNAmgen Inc
 Showing the most relevant articles for your search:NASDAQ:AMGN

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
EU
BEL20
Bel 20
NYSE
KO
Coca Cola
EU
EN
Bouygues
NYSE
MRK
Merck
EU
HO
Thales
EU
BN
Danone
NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
SPI
SP500
S&P 500
EU
RI
Pernod Ricard
NASDAQ
MSFT
Microsoft
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés